Vibration Therapy and Osteopathic Treatment Tested in Adults With Obesity
Tests vibration therapy and manual osteopathic treatment in adults with obesity.
Plain-language title generated from the registry record
Registry title: Systemic Vibratory Therapy and Osteopathic Manipulative Treatment in Individuals With Obesity
Key facts
- Where
- Rio de Janeiro, BrazilSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT06971159, who can take part
Where in Brazil
- Laboratório de Vibrações Mecânicas e Práticas Integrativas - LAVIMPIRio de Janeiro, BrazilTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Laboratorio de Vibraçoes Mecanicas e Praticas Integrativas
- Trial code
- NCT06971159
- Record updated
- 14 May 2025
- Original description
Studies have demonstrated a strong relationship between physical inactivity and the presence of obesity and other cardiovascular risk factors such as hypertension, insulin resistance, diabetes, dyslipidemia, and metabolic syndrome. On the other hand, regular physical exercise has been recommended for the prevention and treatment of cardiovascular diseases, their risk factors, and other chronic conditions.Read full original descriptionShow less
Clinical, Metabolic, Physical, Functional, Biochemical, and Cardiovascular Evaluation in Individuals With Obesity After Performing Systemic Vibratory Therapy and Osteopathic Manipulative Treatment
Studies have demonstrated a strong relationship between physical inactivity and the presence of obesity and other cardiovascular risk factors such as hypertension, insulin resistance, diabetes, dyslipidemia, and metabolic syndrome. On the other hand, regular physical exercise has been recommended for the prevention and treatment of cardiovascular diseases, their risk factors, and other chronic conditions.
Systemic vibratory therapy (SVT) and osteopathic manipulative treatment (OMT) has been proposed as alternative therapies for this population.
The aim of this project is to assess clinical, metabolic, physical, functional and cardiovascular parameters, in individuals with obesity undergoing systemic vibratory therapy and the osteopathic manipulative treatment.
The clinical evaluation included measurements of heart rate variability, systemic blood pressure, heart rate, respiratory rate, oxygen saturation, handgrip dynamometry, the BORG scale, NPS (Numerical Pain Scale), and RPE (Rating of Perceived Exertion) scale; anthropometric measurements including neck, abdominal, hip, arm, thigh and calf circumferences; as well as body composition assessment and anterior trunk flexibility. Additional information was collected, including age, sex, smoking status, physical inactivity, associated comorbidities and medication use.
Laboratory analyses included a complete blood count, total cholesterol and its fractions, triglycerides, creatinine, uric acid, cortisol, glucose, insulin, growth hormone, vitamin D, and other relevant blood parameters. Questionnaires were administered to access the level of physical activity.
Participants were randomized into five groups: systemic vibratory therapy group (SVT), osteopathic manipulative treatment group (OMT), SVT+OMT, OMT+SVT, and control group. The parameters mentioned above are collected before the intervention (baseline), immediately after one session of the respective intervention (acute effect), and after 12 sessions (cumulative effect).
Inclusion: Individuals of both sexes; Individuals with obesity; Over 18 years old.
Exclusion: Uncontrolled untreated hypertension, with elevated systemic blood pressure levels (≥180 x 110 mmHg); Cardiovascular diseases (myocardial infarction/stroke), in the last 6 months; History of spine surgery; Neurological, rheumatological diseases or osteoarticular lesions that hinder movements of the vibrating platform (VP); Serious or disabling diseases, at the discretion of the investigator; Body mass index (BMI) < 30 kg/m2; Atrial fibrillation; Individuals who refuse to sign the Informed Consent Form (ICF) to participate in the study.